RBBP6 Antikörper (AA 154-313)
Kurzübersicht für RBBP6 Antikörper (AA 154-313) (ABIN7870998)
Target
Alle RBBP6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 154-313
-
Verwendungszweck
- PACT Antibody / PRKRA
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids A154-K313) was used as the immunogen for the PACT antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the PACT antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the PACT antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- RBBP6 (Retinoblastoma Binding Protein 6 (RBBP6))
-
Andere Bezeichnung
- PACT
-
Hintergrund
- Protein kinase, interferon-inducible double stranded RNA dependent activator, also known as interferon-inducible double stranded RNA-dependent protein kinase activator A or Protein ACTivator of the interferon-induced protein kinase (PACT) is a protein that in humans is encoded by the PRKRA gene. This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants.
-
UniProt
- O75569
-
Pathways
- Regulatorische RNA Pathways
Target
-